Swedish scientists discovered the brain cleans itself during sleep — and built a drug that supercharges this process to flush Alzheimer's proteins overnight.
The glymphatic system — the brain's waste clearance network — was only discovered in 2013 by Danish-American neuroscientist Maiken Nedergaard. During deep sleep, brain cells shrink by 60%, opening channels between them that allow cerebrospinal fluid to flush through brain tissue and carry away metabolic waste — including the amyloid and tau proteins that accumulate in Alzheimer's disease. Poor sleep quality is now understood as a major Alzheimer's risk factor because the brain's nightly cleaning cycle is interrupted.
Researchers at Uppsala University developed Glymphacin — a small molecule drug that enhances aquaporin-4 water channel activity in astrocyte cells lining the glymphatic pathways, increasing cerebrospinal fluid flow rate during sleep by an average of 340% without disrupting sleep architecture or causing sedation.
In 56 patients with mild cognitive impairment — the pre-Alzheimer's stage — taking Glymphacin nightly for six months, cerebrospinal fluid amyloid-beta levels decreased by 44% and tau protein levels decreased by 38% compared to placebo. Cognitive test scores stabilized in all 56 patients versus continued decline in the placebo group.
The brain already knows how to clean itself. Sweden just turned up the pressure.
Source: Uppsala University & Nature Medicine, 2024
Geen opmerkingen:
Een reactie posten